In summary, we conclude that CAV2 is an oncogenic gene in pancreatic cancer that exerts its oncogenic effect by targeting Wnt7A to activate the Wnt/β-catenin signalling pathway activity. The gene discussed is WNT7A; the disease is familial pancreatic carcinoma.